相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune mechanisms of new therapeutic strategies in MS - Teriflunomide
Malte C. Claussen et al.
CLINICAL IMMUNOLOGY (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interleukin-2/Interleukin-2 Antibody Therapy Induces Target Organ Natural Killer Cells That Inhibit Central Nervous System Inflammation
Junwei Hao et al.
ANNALS OF NEUROLOGY (2011)
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
Sandra Vergo et al.
BRAIN (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years
Nermin Serbecic et al.
PLOS ONE (2011)
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
Joanne L. Jones et al.
BRAIN (2010)
In Vivo Imaging of Partially Reversible Th17 Cell-Induced Neuronal Dysfunction in the Course of Encephalomyelitis
Volker Siffrin et al.
IMMUNITY (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. (vol 9, pg 381, 2010)
D. Wynn et al.
LANCET NEUROLOGY (2010)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial
Mansoureh Togha et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study
Markus Bock et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Multiple sclerosis - candidate mechanisms underlying CNS atrophy
Volker Siffrin et al.
TRENDS IN NEUROSCIENCES (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Daniel Wynn et al.
LANCET NEUROLOGY (2010)
Lower Motor Neuron Loss in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Johannes Vogt et al.
ANNALS OF NEUROLOGY (2009)
Microglial Physiology: Unique Stimuli, Specialized Responses
Richard M. Ransohoff et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Green Tea Epigallocatechin 3-Gallate Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect Against Inducers of Mitochondrial Oxidative Stress in Neurons
Emily K. Schroeder et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Mitochondrial changes within axons in multiple sclerosis
Don J. Mahad et al.
BRAIN (2009)
Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis
Kimmy G. Su et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
Truyen Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice
Ashutosh Mangalam et al.
JOURNAL OF IMMUNOLOGY (2009)
Cytotoxic CD8+ T Cell-Neuron Interactions: Perforin-Dependent Electrical Silencing Precedes But Is Not Causally Linked to Neuronal Cell Death
Sven G. Meuth et al.
JOURNAL OF NEUROSCIENCE (2009)
A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes
Frauke Zipp
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Bruce D. Trapp et al.
LANCET NEUROLOGY (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Flupirtine as Neuroprotective Add-On Therapy in Autoimmune Optic Neuritis
Muriel B. Saettler et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Axon-glial signaling and the glial support of axon function
Klaus-Armin Nave et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Mitochondrial defects in acute multiple sclerosis lesions
Don Mahad et al.
BRAIN (2008)
Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis
Paul S. Giacomini et al.
CURRENT OPINION IN NEUROLOGY (2008)
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs
Xuexian O. Yang et al.
IMMUNITY (2008)
Long-term study of brain 1H-MRS study in multiple sclerosis:: Effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-term 1H-MRS monitoring in multiple sclerosis
Omar Khan et al.
JOURNAL OF NEUROIMAGING (2008)
The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome
Robert Zivadinov et al.
JOURNAL OF NEUROLOGY (2008)
Negative Impact of Statins on Oligodendrocytes and Myelin Formation In Vitro and In Vivo
Steve Klopfleisch et al.
JOURNAL OF NEUROSCIENCE (2008)
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Ludwig Kappos et al.
LANCET (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis - current status
Stephen G. Waxman
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system
Manuel A. Friese et al.
NATURE MEDICINE (2007)
Optical coherence tomography and disease subtype in multiple sclerosis
M. Pulicken et al.
NEUROLOGY (2007)
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E. Gordon-Lipkin et al.
NEUROLOGY (2007)
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis
Sha Mi et al.
NATURE MEDICINE (2007)
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Hannelore Ehrenreich et al.
BRAIN (2007)
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos et al.
LANCET (2007)
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine
Joel A. Black et al.
ANNALS OF NEUROLOGY (2007)
Microglial recruitment, activation, and proliferation in response to primary demyelination
Leah T. Remington et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway
Linrong Lu et al.
IMMUNITY (2007)
Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant
S. Lindquist et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
MR spectroscopy in multiple sclerosis
Nicola De Stefano et al.
JOURNAL OF NEUROIMAGING (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Katarzyna Maresz et al.
NATURE MEDICINE (2007)
New natural history of interferon-β treated relapsing multiple sclerosis
Maria Trojano et al.
ANNALS OF NEUROLOGY (2007)
Evidence for synaptic stripping by cortical microglia
Bruce D. Trapp et al.
GLIA (2007)
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
Joel A. Black et al.
BRAIN (2006)
Brain atrophy in multiple sclerosis: what we know and would like to know
J. H. Simon
MULTIPLE SCLEROSIS JOURNAL (2006)
Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions
Muriel B. Saettler et al.
EXPERIMENTAL NEUROLOGY (2006)
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O'Connor et al.
NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta et al.
ANNALS OF NEUROLOGY (2006)
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
JB Fisher et al.
OPHTHALMOLOGY (2006)
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
A Ligresti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations
F Bagnato et al.
ARCHIVES OF NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia
MA Nikolaeva et al.
JOURNAL OF NEUROSCIENCE (2005)
Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate
J Dörr et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis
SA Trip et al.
ANNALS OF NEUROLOGY (2005)
Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network
H Rosen et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice
RA Linker et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL
O Aktas et al.
NEURON (2005)
Emerging properties of cannabinoid medicines in management of multiple sclerosis
G Pryce et al.
TRENDS IN NEUROSCIENCES (2005)
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
FL Heppner et al.
NATURE MEDICINE (2005)
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS
MJ Craner et al.
GLIA (2005)
Analysis of regulatory CD8 T cells in Qa-1-deficient mice
D Hu et al.
NATURE IMMUNOLOGY (2004)
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis
M Inglese et al.
NEUROIMAGE (2004)
Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue
R Nitsch et al.
JOURNAL OF NEUROSCIENCE (2004)
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
K Schmierer et al.
ANNALS OF NEUROLOGY (2004)
Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
E Brand-Schieber et al.
EXPERIMENTAL NEUROLOGY (2004)
Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis
MB Sättler et al.
CELL DEATH AND DIFFERENTIATION (2004)
New perspectives in the studies on endocannabinoid and cannabis:: Abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application
M Fujiwara et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
JR Oksenberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Patterns of cannabis use among patients with multiple sclerosis
AJ Clark et al.
NEUROLOGY (2004)
Are statins a treatment option for multiple sclerosis?
O Neuhaus et al.
LANCET NEUROLOGY (2004)
Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis
O Aktas et al.
JOURNAL OF IMMUNOLOGY (2004)
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial
M Filippi et al.
LANCET (2004)
Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications
R Arnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
DA Bechtold et al.
ANNALS OF NEUROLOGY (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
G Pryce et al.
BRAIN (2003)
Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor Vβ repertoire during experimental autoimmune encephalomyelitis
H Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures
M Ängehagen et al.
EPILEPSY RESEARCH (2003)
The pleiotropic effects of erythropoietin in the central nervous system
M Buemi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bo et al.
MULTIPLE SCLEROSIS (2003)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study
NF Kalkers et al.
MULTIPLE SCLEROSIS (2002)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF:: implications for multiple sclerosis therapy
T Ziemssen et al.
BRAIN (2002)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Differential mechanisms of action of interferon-β and glatiramer acetate in MS
VW Yong
NEUROLOGY (2002)
Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons
PK Stys et al.
NEUROSCIENCE LETTERS (2002)
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue
LP Zou et al.
NEUROPHARMACOLOGY (2002)
Oligoclonal expansion of memory CD8(+) T cells in cerebrospinal fluid from multiple sclerosis patients
M Jacobsen et al.
BRAIN (2002)
Axonal loss in normal-appearing white matter in a patient with acute MS
C Bjartmar et al.
NEUROLOGY (2001)
A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons
A Wilkins et al.
GLIA (2001)
Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes
I Medana et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
Normalized accurate measurement of longitudinal brain change
SM Smith et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2001)
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
G Comi et al.
ANNALS OF NEUROLOGY (2001)
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2001)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
ML Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
R Nitsch et al.
LANCET (2000)
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Extended observations on MS patients treated with IM interferon-β1a (Avonex™):: implications for modern MS trials and therapeutics -: Presented in part at Pathogenic and Regulatory Cells in Demyelinating Diseases, Rome, Italy, September 12-15, 1999.
L Jacobs et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Multiple sclerosis: Comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
O Neuhaus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
分享论文
